Cargando…
Low-dose synthetic adrenocorticotropic hormone-analog therapy for nephrotic patients: results from a single-center pilot study
INTRODUCTION: This report describes our experience using a low-dose synthetic adrenocorticotropic hormone (ACTH) analog for patients affected by nephrotic syndrome who had not responded to or had relapsed after steroid and immunosuppressive treatments. PATIENTS AND METHODS: Eighteen adult nephrotic...
Autores principales: | Lorusso, Paolo, Bottai, Anna, Mangione, Emanuela, Innocenti, Maurizio, Cupisti, Adamasco, Egidi, Maria Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327400/ https://www.ncbi.nlm.nih.gov/pubmed/25709493 http://dx.doi.org/10.2147/IJNRD.S74349 |
Ejemplares similares
-
Adrenocorticotropic hormone analog use for podocytopathies
por: Filippone, Edward J, et al.
Publicado: (2016) -
Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel
por: Bomback, Andrew S, et al.
Publicado: (2011) -
Real-word adrenocorticotropic hormone treatment for childhood-onset nephrotic syndrome
por: Wang, Ying, et al.
Publicado: (2023) -
Nutritional support in the tertiary care of patients affected by chronic renal insufficiency: report of a step-wise, personalized, pragmatic approach
por: Cupisti, Adamasco, et al.
Publicado: (2016) -
Use of synthetic adrenocorticotropic hormone in patients with IgA nephropathy
por: Prasad, Bhanu, et al.
Publicado: (2018)